Search

M2 PRESSWIRE-September 27, 2022-: WuXi STA Opens First High Potency Oral Drug Product Manufacturing Facility (C)1994-2022 M2 COMMUNICATIONS RDATE:26092022 * New facility expands integrated drug product R&D and manufacturing services [...]

M2 EQUITYBITES-August 30, 2022-AstraZeneca's Evusheld approved for COVID-19 prevention and treatment in Japan (C)2022 M2 COMMUNICATIONS http://www.m2.com Pharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (Nasdaq:AZN) said on Tuesday that Evusheld, its [...]

NORDIC BUSINESS REPORT-August 30, 2022-AstraZeneca's Evusheld approved for COVID-19 prevention and treatment in Japan (C)2022 M2 COMMUNICATIONS http://www.m2.com Pharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (Nasdaq:AZN) said on Tuesday that Evusheld, [...]

M2 PHARMA-August 30, 2022-AstraZeneca's Evusheld approved for COVID-19 prevention and treatment in Japan (C)2022 M2 COMMUNICATIONS Pharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (Nasdaq:AZN) said on Tuesday that Evusheld, its long-acting [...]

M2 PRESSWIRE-November 8, 2021-: United States Aseptic Sampling Market Research Report 2021 (C)1994-2021 M2 COMMUNICATIONS RDATE:08112021 The 'United States Aseptic Sampling Market Size By Type, By Application And Forecast' report [...]

M2 PRESSWIRE-May 3, 2021-: Mankind Pharma: Digital Transformation with Data-Driven Cloud (C)1994-2021 M2 COMMUNICATIONS RDATE:03052021 Accenture Accelerates Mankind Pharma's Digital Transformation with Data-Driven Cloud Platform Redesigns business processes and develops [...]

M2 PHARMA-September 17, 2021-US to commence shipment of an additional 2.58 million COVID-19 vaccine doses to Philippines (C)2021 M2 COMMUNICATIONS The US government will begin shipping 2.58 million more doses [...]

M2 EQUITYBITES-August 24, 2021-US to ship three million doses of Pfizer/ BioNTech's COVID-19 vaccine to Pakistan under COVAX facility (C)2021 M2 COMMUNICATIONS http://www.m2.com The United States will ship over three [...]

M2 PHARMA-August 24, 2021-US to ship three million doses of Pfizer/ BioNTech's COVID-19 vaccine to Pakistan under COVAX facility (C)2021 M2 COMMUNICATIONS The United States will ship over three million [...]

M2 PRESSWIRE-March 13, 2019-: BOC Sciences Launches Novel, Cost-Effective Impurities Synthesis for API Development (C)1994-2019 M2 COMMUNICATIONS RDATE:13032019 BOC Sciences, a leading global supplier and manufacturer of premium chemicals, has [...]

MANews-(C)2009-2019 17 June 2019 - Ohio, US-based drug development and commercialisation partner Camargo Pharmaceutical Services has agreed to acquire Montreal-based drug development partner InSymbiosis to improve R and D outsourcing [...]

M2 EQUITYBITES-June 17, 2019-Camargo Pharmaceutical Acquires InSymbiosis to Enhance Drug Development Services (C)2019 M2 COMMUNICATIONS http://www.m2.com 17 June 2019 - Ohio, US-based drug development and commercialisation partner Camargo Pharmaceutical Services [...]

M2 PRESSWIRE-October 31, 2017-: J. Walter Thompson takes majority stake in e-commerce specialist Enext in Brazil (C)1994-2017 M2 COMMUNICATIONS RDATE:31102017 WPP announces that J. Walter Thompson Company, its wholly owned [...]

M2 PRESSWIRE-July 26, 2017-: ABL&E appointed to represent Gamlen Instruments (C)1994-2017 M2 COMMUNICATIONS RDATE:26072017 Gamlen Instruments has appointed ABL&E as the exclusive distributor for Gamlen Instruments in Eastern Europe. ABL&E [...]

M2 PRESSWIRE-June 15, 2017-: InoLife Technologies Inc: Is a drug delivery company committed to commercializing innovative product for the care and cure of our global clients (C)1994-2017 M2 COMMUNICATIONS RDATE:14062017 [...]

M2 PHARMA-October 23, 2018-Enterome SA and Takeda to co-develop and co-promote investigational drug candidate EB8018 (C)2018 M2 COMMUNICATIONS Biotech company Enterome SA reported on Monday the launch of global licensing, [...]

M2 EQUITYBITES-October 23, 2018-Enterome SA and Takeda to co-develop and co-promote investigational drug candidate EB8018 (C)2018 M2 COMMUNICATIONS http://www.m2.com Biotech company Enterome SA reported on Monday the launch of global [...]

M2 PHARMA-July 3, 2018-Novocure elects Pritesh Shah as chief commercial officer (C)2018 M2 COMMUNICATIONS Oncology company Novocure (NASDAQ:NVCR) revealed on Monday the addition of Pritesh Shah as its chief commercial [...]

M2 EQUITYBITES-July 3, 2018-Novocure elects Pritesh Shah as chief commercial officer (C)2018 M2 COMMUNICATIONS http://www.m2.com Oncology company Novocure (NASDAQ:NVCR) revealed on Monday the addition of Pritesh Shah as its chief [...]

M2 PRESSWIRE-August 30, 2016-: InoLife is a drug delivery company committed to commercializing innovative product for the care and cure of our global clients. The company has acquired the intellectual [...]

M2 EQUITYBITES-October 30, 2017-Astellas reports global branding campaign via CNBC platforms (C)2017 M2 COMMUNICATIONS http://www.m2.com Pharmaceutical company Astellas Pharma Inc on Friday announced the launch of its next global corporate [...]

M2 PHARMA-August 15, 2017-MaxCyte elects Brad Calvin of EVP of Global Marketing (C)2017 M2 COMMUNICATIONS Cell-based medicines company MaxCyte reported on Monday the appointment of Brad Calvin as executive vice [...]

M2 EQUITYBITES-August 15, 2017-MaxCyte elects Brad Calvin of EVP of Global Marketing (C)2017 M2 COMMUNICATIONS http://www.m2.com Cell-based medicines company MaxCyte reported on Monday the appointment of Brad Calvin as executive [...]

M2 PHARMA-March 27, 2017-Amryt Pharma appoints new CCO (C)2017 M2 COMMUNICATIONS Amryt Pharmaceuticals plc (LON: AMYT) has made a new senior management appointment in the form of David Allmond as [...]

M2 EQUITYBITES-March 27, 2017-Amryt Pharma appoints new CCO (C)2017 M2 COMMUNICATIONS http://www.m2.com Amryt Pharmaceuticals plc (LON: AMYT) has made a new senior management appointment in the form of David Allmond [...]

NORDIC BUSINESS REPORT-May 24, 2016-Nordic Nanovector elects new board members (C)2016 M2 COMMUNICATIONS http://www.m2.com Nordic Nanovector ASA (Oslo:NANO) announced on Monday that the Annual General Meeting, held on 19 May [...]

M2 EQUITYBITES-May 24, 2016-Nordic Nanovector elects new board members (C)2016 M2 COMMUNICATIONS http://www.m2.com Nordic Nanovector ASA (Oslo:NANO) announced on Monday that the Annual General Meeting, held on 19 May 2016, [...]

M2 PHARMA-March 11, 2016-Synergy Pharmaceuticals elects Marino Garcia as chief strategy officer (C)2016 M2 COMMUNICATIONS Biopharmaceutical company Synergy Pharmaceuticals (NasdaqGS:SGYP) reported on Thursday the addition of Marino Garcia as its [...]

M2 EQUITYBITES-March 11, 2016-Synergy Pharmaceuticals elects Marino Garcia as chief strategy officer (C)2016 M2 COMMUNICATIONS http://www.m2.com Biopharmaceutical company Synergy Pharmaceuticals (NasdaqGS:SGYP) reported on Thursday the addition of Marino Garcia as [...]

M2 PRESSWIRE-October 15, 2014-BUYINS.NET: Market Maker Surveillance Report. PFE, C, NOK, BAC, MSFT, GRPN, Bullishly Biased Price Friction For Tuesday, October 14th 2014 (C)1994-2014 M2 COMMUNICATIONS RDATE:15102014 BUYINS.NET / www.buyins.net, [...]

MANews-(C)2009-2015 The following is a list of deals covered in detail by M and A Navigator this week: -LITTELFUSE TO ACQUIRE TE CONNECTIVITY'S CIRCUIT PROTECTION BUSINESS FOR USD 350M US-based [...]

M2 EQUITYBITES-November 10, 2015-M and A Navigator: Deal pipeline -10 November (C)2015 M2 COMMUNICATIONS http://www.m2.com The following is a list of deals covered in detail by M and A Navigator [...]

M2 EQUITYBITES-August 3, 2015-Frequentz announces new global business development lead (C)2015 M2 COMMUNICATIONS http://www.m2.com Frequentz Inc., via its fourth generation EPCIS solution, said it has announced Ranjit Pradhan in the [...]

TELECOMWORLDWIRE-August 3, 2015-Frequentz announces new global business development lead (C)1994-2015 M2 COMMUNICATIONS http://www.m2.com Frequentz Inc., via its fourth generation EPCIS solution, said it has announced Ranjit Pradhan in the new [...]

MANews-(C)2009-2015 11 June 2015 - Irish specialty pharmaceutical Altan Pharma Ltd. has acquired a privately held group of Spanish companies, The GES Group, which develops, manufactures and markets specialty injectable [...]

M2 PRESSWIRE-May 7, 2013-BUYINS.NET: Market Maker Surveillance Report. C, BAC, SIRI, JPM, S, MYL, Highest Net Buy Volume With Lowest Price Friction For Monday, May 6th 2013(C)1994-2013 M2 COMMUNICATIONS RDATE:07052013 [...]

M2 PRESSWIRE-February 18, 2011-: Sigma-Aldrich Takes Over Global Distribution for BASF Pharma Excipients in Small Pack Sizes; University and Development Lab Supplies Now Available from Sigma-Aldrich(C)1994-2011 M2 COMMUNICATIONS RDATE:17022011 Ludwigshafen [...]

M2 PHARMA-February 6, 2015-RXi Pharmaceuticals enters into exclusive global licensing agreement for Samcyprone (C)2015 M2 COMMUNICATIONS Biotechnology company RXi Pharmaceuticals (NasdaqCM:RXII) announced Thursday that it has completed its exclusive global [...]

M2 EQUITYBITES-February 6, 2015-RXi Pharmaceuticals enters into exclusive global licensing agreement for Samcyprone (C)2015 M2 COMMUNICATIONS http://www.m2.com Biotechnology company RXi Pharmaceuticals (NasdaqCM:RXII) announced Thursday that it has completed its exclusive [...]

M2 PHARMA-November 7, 2014-Versartis elects Keith Lui as VP of Marketing to prepare the commercialisation of VRS-317 (C)2014 M2 COMMUNICATIONS Biopharmaceutical company Versartis (NasdaqGS:VSAR) reported on Thursday the appointment of [...]

M2 EQUITYBITES-November 7, 2014-Versartis elects Keith Lui as VP of Marketing to prepare the commercialisation of VRS-317 (C)2014 M2 COMMUNICATIONS http://www.m2.com Biopharmaceutical company Versartis (NasdaqGS:VSAR) reported on Thursday the appointment [...]

M2 PHARMA-September 18, 2014-Otsuka Pharmaceutical to further develop, commercialise NuView Life Sciences' VPAC1 cancer biomarker (C)2014 M2 COMMUNICATIONS 18 September 2014 - US NuView Life Sciences Inc said Wednesday it [...]

MANews-(C)2009-2014 4 February 2014 - Italian pharmaceutical group Chiesi Farmaceutici SpA on Tuesday said it had completed the takeover of Cornerstone Therapeutics Inc (NASDAQ:CRTX) and had taken the US sector [...]

M2 EQUITYBITES-February 4, 2014-Chiesi Farmaceutici wraps up Cornerstone deal (C)2014 M2 COMMUNICATIONS http://www.m2.com 4 February 2014 - Italian pharmaceutical group Chiesi Farmaceutici SpA on Tuesday said it had completed the [...]

M2 EQUITYBITES-January 23, 2013-J&J looks into options for diagnostics unit, including sale(C)2013 M2 COMMUNICATIONS http://www.m2.com 23 January 2013 - US healthcare products group Johnson & Johnson (NYSE:JNJ), or J&J, said [...]

M2 EQUITYBITES-December 21, 2012-Nutra Pharma Corporation updates sales and marketing activities of OTC pain reliever, Nyloxin(C)2012 M2 COMMUNICATIONS http://www.m2.com Biotechnology company Nutra Pharma Corp (OTC Markets:NPHC) said on Thursday that [...]

M2 PHARMA-September 27, 2012-Cardiome Pharma Corp receives global marketing and development rights for vernakalant licensed earlier to Merck(C)2012 M2 COMMUNICATIONS Biopharmaceutical company Cardiome Pharma Corp (NasdaqGM:CRME) (TSX:COM.TO) stated on Wednesday [...]

M2 EQUITYBITES-September 27, 2012-Cardiome Pharma Corp receives global marketing and development rights for vernakalant licensed earlier to Merck(C)2012 M2 COMMUNICATIONS http://www.m2.com Biopharmaceutical company Cardiome Pharma Corp (NasdaqGM:CRME) (TSX:COM.TO) stated on [...]

MANews-(C)2009-2012 12 April 2012 â[euro]' An investor consortium led by US private equity outfit Source Capital LLC has partnered with the management of Sun and Skin Care Research Inc (SSCR) [...]